閉経前不眠症に対する統合的治療:体系的レビューとメタ解析
Boxiang Yang1, Shengwen Jiang1, Yubo Teng1
1School of Graduate, Heilongjiang University of Chinese Medicine, Harbin, China.
Frontiers in neurology
|September 5, 2025
まとめ
統合された治療と薬物療法 (AP) は,睡眠の質を改善し,不安を軽減し,ホルモンのバランスをとることで,閉経前不眠症 (PMI) を効果的に治療します. この組み合わせはPMIを患っている女性にとって重要な臨床的価値をもたらします.
科学分野:
- 統合医療
- 生殖内分泌学
- 睡眠医学
背景:
- 閉経前不眠症 (PMI) は,ホルモンの変動と神経精神的要因に関連し,生活の質を低下させる一般的な状態です.
- エストロゲンとプロゲステロンの不均衡は,閉経前期の睡眠障害の主な要因です.
- 効果的なPMI管理戦略は女性の福祉にとって不可欠です.
研究 の 目的:
- 閉経前不眠症 (PMI) の治療における統合療法 (AP) の有効性を体系的に評価する.
- 新しい治療法としてPMIに関する 根拠に基づいた洞察を提供すること.
- 閉経前期の女性の睡眠質,不安,ホルモンプロフィールに対するAPの影響を評価する.
主な方法:
- ランダム化対照試験 (RCT) の体系的レビューとメタ解析は,8つの主要なデータベースで行われました.
- 効果率,ハミルトン不安スケール (HAMA),中国伝統医学症候群 (TCMS),ピッツバーグ睡眠品質指数 (PSQI),改変されたクーパーマン指数 (KMI),ホルモンレベル (LH,FSH,E2) などを評価した研究も含まれていた.
- バイアスのリスク,異質性,証拠の質は確立された方法論 (コクランハンドブック,GRADE) を用いて評価された.
主要な成果:
- 12件のRCT (969人の患者) のメタアナリシスは,APがPMI治療の有効率を大幅に改善したことを示しました.
- APはHAMA,TCMS,PSQI,KMIのスコアを大幅に低下させ,不安,TCMで定義された症候群,睡眠の質,更年期症状の改善を示した.
- APはまた,LHとFSHの減少とエストラディオール (E2) の増加を含む,ホルモンレベルの大幅な改善をもたらしました.
結論:
- 統合された治療と薬物療法 (AP) は,閉経前不眠症 (PMI) の非常に効果的な治療法であり,有意な臨床的利益をもたらします.
- APはPMIの女性における心理的,睡眠関連の,ホルモンのパラメータに好ましい影響を及ぼします.
- これらの発見を固め,長期的な有効性を探求するために,長期フォローアップを伴う大規模なマルチセンターRCTを推奨する.
さらに関連する動画
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
2.5K
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
500
関連する概念動画
01:19Management of Insomnia
319
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
319
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
236
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
236
01:27Insomnia
123
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
123
01:23Sedatives and Hypnotics: Overview
629
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
629
01:26Anxiolytic Drugs: Overview
479
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
479
01:14CNS Depressants: Barbiturates and Benzodiazepines
462
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
462